Atlas Trials

A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma

Clinical trial NCT01593748 · COMPLETED

Trial details

NCT number
NCT01593748
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
2012-09-27
Primary completion
2019-04-24
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.